Literature DB >> 34987089

Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review.

Céline Nicolas1, Natalie E Zlebnik1, Mehdi Farokhnia2, Lorenzo Leggio2, Satoshi Ikemoto2, Yavin Shaham1.   

Abstract

A widely held dogma in the preclinical addiction field is that females are more vulnerable than males to drug craving and relapse. Here, we first review clinical studies on sex differences in psychostimulant and opioid craving and relapse. Next, we review preclinical studies on sex differences in psychostimulant and opioid reinstatement of drug seeking after extinction of drug self-administration, and incubation of drug craving (time-dependent increase in drug seeking during abstinence). We also discuss ovarian hormones' role in relapse and craving in humans and animal models and speculate on brain mechanisms underlying their role in cocaine craving and relapse in rodent models. Finally, we discuss imaging studies on brain responses to cocaine cues and stress in men and women.The results of the clinical studies reviewed do not appear to support the notion that women are more vulnerable to psychostimulant and opioid craving and relapse. However, this conclusion is tentative because most of the studies reviewed were correlational, not sufficiently powered, and not a priori designed to detect sex differences. Additionally, imaging studies suggest sex differences in brain responses to cocaine cues and stress. The results of the preclinical studies reviewed provide evidence for sex differences in stress-induced reinstatement and incubation of cocaine craving but not cue- or cocaine-induced reinstatement of cocaine seeking. These sex differences are modulated in part by ovarian hormones. In contrast, the available data do not support the notion of sex differences in craving and relapse/reinstatement for methamphetamine or opioids in rodent models. SIGNIFICANCE STATEMENT: This systematic review summarizes clinical and preclinical studies on sex differences in psychostimulant and opioid craving and relapse. Results of the clinical studies reviewed do not appear to support the notion that women are more vulnerable to psychostimulant and opioid craving and relapse. Results of preclinical studies reviewed provide evidence for sex differences in reinstatement and incubation of cocaine seeking but not for reinstatement or incubation of methamphetamine or opioid seeking. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34987089     DOI: 10.1124/pharmrev.121.000367

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  13 in total

Review 1.  Factors modulating the incubation of drug and non-drug craving and their clinical implications.

Authors:  Marco Venniro; Ingrid Reverte; Leslie A Ramsey; Kimberly M Papastrat; Ginevra D'Ottavio; Michele Stanislaw Milella; Xuan Li; Jeffrey W Grimm; Daniele Caprioli
Journal:  Neurosci Biobehav Rev       Date:  2021-09-28       Impact factor: 8.989

2.  Investigating discriminative stimulus modulation of opioid seeking after conflict-induced abstinence in sign- and goal-tracking rats.

Authors:  David A Martin; Sara E Keefer; Donna J Calu
Journal:  Psychopharmacology (Berl)       Date:  2022-08-16       Impact factor: 4.415

3.  Reinforcing effects of phenethylamine analogs found in dietary supplements.

Authors:  Shelby A McGriff; Michael R Chojnacki; Eric B Thorndike; Kenner C Rice; Michael H Baumann; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2022-10-03       Impact factor: 4.415

4.  Selective Inhibition of PDE4B Reduces Methamphetamine Reinforcement in Two C57BL/6 Substrains.

Authors:  Kevin M Honeywell; Eliyana Van Doren; Karen K Szumlinski
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

5.  Transcriptomics in the nucleus accumbens shell reveal sex- and reinforcer-specific signatures associated with morphine and sucrose craving.

Authors:  Hannah L Mayberry; Charlotte C Bavley; Reza Karbalaei; Drew R Peterson; Angela R Bongiovanni; Alexandra S Ellis; Sara H Downey; Andre B Toussaint; Mathieu E Wimmer
Journal:  Neuropsychopharmacology       Date:  2022-02-21       Impact factor: 8.294

Review 6.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

7.  Dissociation Between Incubation of Cocaine Craving and Anxiety-Related Behaviors After Continuous and Intermittent Access Self-Administration.

Authors:  Celine Nicolas; Trinity I Russell; Yavin Shaham; Satoshi Ikemoto
Journal:  Front Neurosci       Date:  2022-02-07       Impact factor: 4.677

8.  Opioid and Sucrose Craving Are Accompanied by Unique Behavioral and Affective Profiles after Extended Abstinence in Male and Female Rats.

Authors:  Hannah L Mayberry; Heather A DeSalvo; Charlotte C Bavley; Sara H Downey; Cindy Lam; Charita Kunta; Ricardo P Fortuna; Priya H Doshi; Elizabeth B Smedley; Mathieu E Wimmer
Journal:  eNeuro       Date:  2022-04-12

Review 9.  Is Illicit Substance Use Gender-Specific? The Basic Points of Mental and Health Disorders.

Authors:  Ekaterina Georgieva; Krasimira Benkova; Nadya Vlaeva; Yanka Karamalakova; Radostina Miteva; Hristo Abrashev; Galina Nikolova
Journal:  Toxics       Date:  2022-06-22

10.  Longitudinal Correlates of Suicide Ideation in People who use Drugs during the COVID-19 Pandemic.

Authors:  Kasey Claborn; Elizabeth Lippard; Fiona Conway
Journal:  Res Sq       Date:  2022-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.